Cargando…

Biochemical pathways mediated by KLK6 protease in breast cancer

Kallikrein‐related peptidase 6 (KLK6) is a serine protease normally expressed in mammary tissue and aberrantly regulated in breast cancer. At physiological levels, KLK6 functions as a suppressor of breast cancer, while its aberrant overexpression (> 50‐fold higher than normal) is characteristic o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pampalakis, Georgios, Zingkou, Eleni, Sidiropoulos, Konstantinos Gus, Diamandis, Eleftherios P., Zoumpourlis, Vassilis, Yousef, George M., Sotiropoulou, Georgia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822253/ https://www.ncbi.nlm.nih.gov/pubmed/30980596 http://dx.doi.org/10.1002/1878-0261.12493

Ejemplares similares

Novel specific activity-based probes validate KLK proteases as druggable targets
por: Sotiropoulou, Georgia, et al.
Publicado: (2022)

The KLK5 protease suppresses breast cancer by repressing the mevalonate pathway
por: Pampalakis, Georgios, et al.
Publicado: (2013)

Activity-Based Probes for Proteases Pave the Way to Theranostic Applications
por: Sotiropoulou, Georgia, et al.
Publicado: (2022)

Kallikreins emerge as new regulators of viral infections
por: Pampalakis, Georgios, et al.
Publicado: (2021)

Development and immunochemical evaluation of a novel chicken IgY antibody specific for KLK6
por: Sotiropoulou, Georgia, et al.
Publicado: (2012)

A chemogenomic approach is required for effective treatment of amyotrophic lateral sclerosis
por: Pampalakis, Georgios, et al.
Publicado: (2022)

KLK6 proteolysis is implicated in the turnover and uptake of extracellular alpha-synuclein species
por: Pampalakis, Georgios, et al.
Publicado: (2016)

KLK5 Inactivation Reverses Cutaneous Hallmarks of Netherton Syndrome
por: Furio, Laetitia, et al.
Publicado: (2015)

Genetically-modified stem cells in treatment of human diseases: Tissue kallikrein (KLK1)-based targeted therapy (Review)
por: Devetzi, Marina, et al.
Publicado: (2018)

Functional proteomic profiling reveals KLK13 and TMPRSS11D as active proteases in the lower female reproductive tract
por: Muytjens, Carla M.J., et al.
Publicado: (2018)

Kallikrein-related peptidase 5 induces miRNA-mediated anti-oncogenic pathways in breast cancer
por: Sidiropoulos, Konstantinos G., et al.
Publicado: (2014)

Co-expression of KLK6 and KLK10 as prognostic factors for survival in pancreatic ductal adenocarcinoma
por: Rückert, F, et al.
Publicado: (2008)

KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma
por: White, N M A, et al.
Publicado: (2009)

Emerging clinical importance of the cancer biomarkers kallikrein-related peptidases (KLK) in female and male reproductive organ malignancies
por: Schmitt, Manfred, et al.
Publicado: (2013)

Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes
por: Tamir, Ayala, et al.
Publicado: (2014)

Kallikrein 6 protease advances colon tumorigenesis via induction of the high mobility group A2 protein
por: Chen, Hwudaurw, et al.
Publicado: (2019)

Evolutionary History of Tissue Kallikreins
por: Pavlopoulou, Athanasia, et al.
Publicado: (2010)

Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer
por: Kim, H, et al.
Publicado: (2001)

Netrin-1 overexpression is predictive of ovarian malignancies
por: Papanastasiou, Anastasios D., et al.
Publicado: (2011)

Distinct cholesterogenic and lipidogenic gene expression patterns in ovarian cancer - a new pool of biomarkers
por: Pampalakis, Georgios, et al.
Publicado: (2015)

Prognostic value of kallikrein-related peptidase 7 (KLK7) mRNA expression in advanced high-grade serous ovarian cancer
por: Gong, Weiwei, et al.
Publicado: (2020)

Human kallikrein gene 13 (KLK13) expression by quantitative RT–PCR: an independent indicator of favourable prognosis in breast cancer
por: Chang, A, et al.
Publicado: (2002)

A KLK6 Activity-Based Probe Reveals a Role for KLK6 Activity in Pancreatic Cancer Cell Invasion
por: Zhang, Leran, et al.
Publicado: (2022)

MMP20, KLK4, and MMP20/KLK4 double null mice define roles for matrix proteases during dental enamel formation
por: Hu, Yuanyuan, et al.
Publicado: (2015)

The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancer
por: Yousef, G M, et al.
Publicado: (2002)

Stable flow-induced expression of KLK10 inhibits endothelial inflammation and atherosclerosis
por: Williams, Darian, et al.
Publicado: (2022)

A comprehensive resequence analysis of the KLK15–KLK3–KLK2 locus on chromosome 19q13.33
por: Parikh, Hemang, et al.
Publicado: (2009)

The promoter and the enhancer region of the KLK 3 (prostate specific antigen) gene is frequently mutated in breast tumours and in breast carcinoma cell lines
por: Majumdar, S, et al.
Publicado: (1999)

Birth-and-Death of KLK3 and KLK2 in Primates: Evolution Driven by Reproductive Biology
por: Marques, Patrícia Isabel, et al.
Publicado: (2012)

KLK4T2 Is a Hormonally Regulated Transcript from the KLK4 Locus
por: Lundwall, Åke, et al.
Publicado: (2021)

Correlation between KLK6 expression and the clinicopathological features of glioma
por: Lou, Jiangtao, et al.
Publicado: (2014)

Scalable synthesis and structural characterization of reversible KLK6 inhibitors
por: Baumann, Andreas, et al.
Publicado: (2022)

KLK5 and KLK7 Ablation Fully Rescues Lethality of Netherton Syndrome-Like Phenotype
por: Kasparek, Petr, et al.
Publicado: (2017)

KLK6 Promotes Growth, Migration, and Invasion of Gastric Cancer Cells
por: Zhu, Shengxing, et al.
Publicado: (2018)

Correction: Scalable synthesis and structural characterization of reversible KLK6 inhibitors
por: Baumann, Andreas, et al.
Publicado: (2022)

KLK-targeted Therapies for Prostate Cancer
por: Hannu, Koistinen, et al.
Publicado: (2014)

KLK3 in the Regulation of Angiogenesis—Tumorigenic or Not?
por: Koistinen, Hannu, et al.
Publicado: (2021)

Expression of the normal epithelial cell-specific 1 (NES1; KLK10) candidate tumour suppressor gene in normal and malignant testicular tissue
por: Luo, L-Y, et al.
Publicado: (2001)

Diagnostic value of KLK6 as an ovarian cancer biomarker: A meta-analysis
por: YANG, FAN, et al.
Publicado: (2016)

A Novel Mutation of the KLK6 Gene in a Family With Knee Osteoarthritis
por: Ge, Yanzhi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gjjgv08ffdq9ste0cjgs0pqrdc